|
Re: Explanation of difference between Endcrinology and CVD
|
7
|
Resverlogix Corp.
|
Oct 06, 2015 02:51PM
|
|
Re: looks like poc/cutt...
|
1
|
Resverlogix Corp.
|
Oct 07, 2015 02:52PM
|
|
Lilly to Discontinue Development of Evacetrapib
|
2
|
Resverlogix Corp.
|
Oct 12, 2015 08:54AM
|
|
Re: Lilly to Discontinue Development of Evacetrapib
|
5
|
Resverlogix Corp.
|
Oct 12, 2015 09:58AM
|
|
Cleveland Clinic's Nissen says CETP inhibition unlikely to work
|
5
|
Resverlogix Corp.
|
Oct 12, 2015 10:13AM
|
|
Re: BearDown, Ledenfrog, Tundup and all other experts.....
|
10
|
Resverlogix Corp.
|
Oct 20, 2015 04:34AM
|
|
Citigroup note on Epigenetics - a big initiation note published on 22 October
|
9
|
Resverlogix Corp.
|
Oct 26, 2015 08:59AM
|
|
Re: Resverlogix Commences Phase 3 Clinical Trial BETonMACE With Apabetalone
|
1
|
Resverlogix Corp.
|
Oct 26, 2015 09:59AM
|
|
Re: Citigroup note on Epigenetics - a big initiation note published on 22 October
|
9
|
Resverlogix Corp.
|
Oct 27, 2015 09:36AM
|
|
Re: A new mathematical formula for RVX
|
10
|
Resverlogix Corp.
|
Nov 06, 2015 12:25PM
|
|
Eerily quiet....
|
3
|
Resverlogix Corp.
|
Feb 04, 2016 03:38PM
|
|
Re: Futility Analysis - Digging Deeper
|
3
|
Resverlogix Corp.
|
Feb 19, 2016 12:57PM
|
|
Re: Futility Analysis - Digging Deeper
|
3
|
Resverlogix Corp.
|
Feb 19, 2016 01:18PM
|
|
this is ridiculous
|
3
|
Resverlogix Corp.
|
Mar 31, 2016 02:41PM
|
|
Cowen presentation significance
|
8
|
Resverlogix Corp.
|
Mar 14, 2017 03:27AM
|
|
Friday fun - a trip down memory lane
|
3
|
Resverlogix Corp.
|
Mar 17, 2017 07:54AM
|
|
RVX vs Valeant
|
3
|
Resverlogix Corp.
|
Mar 17, 2017 08:18AM
|
|
Re: Friday fun - a trip down memory lane
|
1
|
Resverlogix Corp.
|
Mar 17, 2017 10:31AM
|
|
The positive view
|
8
|
Resverlogix Corp.
|
Oct 13, 2017 12:29PM
|
|
Pointing in the right direction & bogus Lilly
|
20
|
Resverlogix Corp.
|
Jun 21, 2018 08:46AM
|
